AU
UK
CA
NZ
IND
US
Last update at 2026-06-12T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
ALGN Stock Might Rise Following the NMPA Approval in China
Fri 16 May 25, 11:59 AMThere May Be Reason For Hope In Align Technology's (NASDAQ:ALGN) Disappointing Earnings
Fri 16 May 25, 10:18 AMHere's How Much a $1000 Investment in Align Technology Made 10 Years Ago Would Be Worth Today
Thu 15 May 25, 12:30 PMALGN Q1 Earnings Call: New Product Launches and International Growth Offset Margin Pressure
Wed 14 May 25, 02:15 PMZacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology
Wed 14 May 25, 12:09 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 585.29M | 608.96M | 641.20M | 599.06M | 1012.42M |
| Minority interest | - | - | - | - | - |
| Net income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M |
| Selling general administrative | 1755.79M | 1578.19M | 1710.94M | 1674.47M | 1708.64M |
| Selling and marketing expenses | - | 185.00M | - | - | - |
| Gross profit | 2756.90M | 2799.16M | 2706.86M | 2633.78M | 2935.36M |
| Reconciled depreciation | 237.44M | 145.03M | 142.37M | 125.79M | 108.73M |
| Ebit | 585.29M | 671.76M | 643.34M | 642.60M | 867.67M |
| Ebitda | 765.87M | 816.80M | 643.34M | 665.50M | 976.40M |
| Depreciation and amortization | 180.59M | 145.03M | -13.98900M | 22.91M | 108.73M |
| Non operating income net other | - | - | - | - | 36.02M |
| Operating income | 616.22M | 607.63M | 643.34M | 642.60M | 976.40M |
| Other operating expenses | 3418.75M | 3391.38M | 3205.61M | 3080.59M | 2976.18M |
| Interest expense | - | - | 2.13M | 5.37M | 36.02M |
| Tax provision | 174.94M | 187.60M | 220.83M | 237.48M | 240.40M |
| Interest income | 16.05M | 20.22M | 15.04M | 5.37M | 3.10M |
| Net interest income | 16.05M | 20.22M | 15.04M | 5.37M | 3.10M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 174.94M | 187.60M | 196.15M | 237.48M | 240.40M |
| Total revenue | 4034.96M | 3999.01M | 3862.26M | 3734.64M | 3952.58M |
| Total operating expenses | 2140.68M | 2191.53M | 2050.21M | 1979.73M | 1958.95M |
| Cost of revenue | 1278.07M | 1199.85M | 1155.40M | 1100.86M | 1017.23M |
| Total other income expense net | -30.92900M | 1.33M | -2.13400M | -43.53800M | 36.02M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 410.35M | 421.36M | 362.81M | 361.57M | 772.02M |
| Net income applicable to common shares | - | - | - | 361.57M | 772.02M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 6233.69M | 6214.60M | 6083.88M | 5947.95M | 5942.11M |
| Intangible assets | 93.93M | 103.49M | 82.12M | 95.72M | 109.71M |
| Earning assets | - | - | - | - | - |
| Other current assets | 137.74M | 164.55M | 273.55M | 226.37M | 125.09M |
| Total liab | 2184.55M | 2362.61M | 2453.39M | 2346.59M | 2319.40M |
| Total stockholder equity | 4049.15M | 3851.99M | 3630.49M | 3601.36M | 3622.71M |
| Deferred long term liab | - | - | - | 27.40M | 31.10M |
| Other current liab | 504.81M | 470.66M | 496.13M | 427.80M | 584.60M |
| Common stock | 0.00700M | 0.00700M | 0.00700M | 0.00800M | 0.00800M |
| Capital stock | 0.00700M | 0.00700M | 0.00700M | 0.00800M | 0.00800M |
| Retained earnings | 2464.16M | 2483.77M | 2447.17M | 2566.69M | 2619.37M |
| Other liab | - | - | - | 320.37M | 292.67M |
| Good will | 491.83M | 442.63M | 419.53M | 407.55M | 418.55M |
| Other assets | - | - | - | 1627.57M | 1591.28M |
| Cash | 1078.99M | 1043.89M | 937.44M | 942.05M | 1099.37M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1920.02M | 2038.03M | 2066.61M | 1925.89M | 1924.07M |
| Current deferred revenue | 1261.82M | 1331.15M | 1427.71M | 1343.64M | 1152.87M |
| Net debt | -964.54500M | -924.61000M | -840.47000M | -815.14200M | -996.71400M |
| Short term debt | 31.94M | 31.06M | 29.65M | 26.57M | 22.72M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 114.45M | 119.28M | 96.97M | 126.91M | 102.66M |
| Other stockholder equity | 1509.60M | 1362.23M | 1162.14M | 1044.95M | 999.01M |
| Property plant equipment | - | - | - | 1350.73M | 1203.18M |
| Total current assets | 2616.56M | 2492.44M | 2446.62M | 2424.39M | 2494.07M |
| Long term investments | - | 0.00000M | 8.02M | 41.98M | 125.32M |
| Net tangible assets | - | - | - | 3098.09M | 3094.46M |
| Short term investments | 15.92M | 0.00000M | 35.30M | 57.53M | 71.97M |
| Net receivables | 1157.58M | 1029.71M | 903.42M | 859.68M | 897.20M |
| Long term debt | - | - | - | - | - |
| Inventory | 226.34M | 254.29M | 296.90M | 338.75M | 230.23M |
| Accounts payable | 121.45M | 108.69M | 113.12M | 127.87M | 163.89M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 75.39M | 5.98M | 21.17M | -10.28400M | 4.33M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | 0.00800M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | 2619.37M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 278.05M | 234.16M | 128.68M | 55.83M | 57.51M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 3617.13M | 3722.16M | 3637.26M | 3523.56M | 3448.03M |
| Capital lease obligations | 114.45M | 119.28M | 126.62M | 100.33M | 102.66M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00000M | -254.91200M | -238.42900M | -213.31600M | -563.43000M |
| Change to liabilities | - | - | - | 205.36M | 653.38M |
| Total cashflows from investing activities | -112.44500M | -254.91200M | -195.94300M | -213.31600M | -563.43000M |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -464.58000M | -355.72200M | -598.34000M | -501.68600M | -458.33200M |
| Change to operating activities | - | - | - | -187.45600M | 33.92M |
| Net income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M |
| Change in cash | 51.22M | 106.44M | -3.83600M | -157.78400M | 138.66M |
| Begin period cash flow | 1044.96M | 938.52M | 942.36M | 1100.14M | 961.47M |
| End period cash flow | 1096.19M | 1044.96M | 938.52M | 942.36M | 1100.14M |
| Total cash from operating activities | 593.22M | 738.23M | 785.78M | 568.73M | 1172.54M |
| Issuance of capital stock | 21.75M | 25.28M | 26.59M | 26.15M | 25.62M |
| Depreciation | 237.44M | 145.03M | 142.40M | 125.79M | 108.73M |
| Other cashflows from investing activities | -112.44500M | 0.23M | 0.28M | -2.21100M | -563.43000M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 0.81M | 25.05M | 30.17M | -130.09700M | -112.45000M |
| Change to account receivables | -139.90900M | -153.48700M | -104.61400M | 21.55M | -262.06600M |
| Sale purchase of stock | -465.93900M | -352.87800M | -592.36000M | -435.03600M | -375.03800M |
| Other cashflows from financing activities | -20.39000M | -28.12500M | -32.57500M | -92.79900M | -108.91700M |
| Change to netincome | - | - | - | 165.68M | 1172.54M |
| Capital expenditures | 102.44M | 115.58M | 177.72M | 291.90M | 401.10M |
| Change receivables | - | - | - | - | -262.06600M |
| Cash flows other operating | - | - | - | - | -141.22200M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | 150.78M |
| Change in working capital | -356.01500M | -72.43300M | -7.89200M | -84.31400M | 154.24M |
| Stock based compensation | 185.87M | 173.70M | 154.03M | 133.37M | 114.34M |
| Other non cash items | 268.37M | 44.81M | 70.83M | 71.81M | 7.77M |
| Free cash flow | 490.78M | 622.65M | 608.06M | 276.83M | 771.45M |
Sector: Healthcare Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALGN Align Technology Inc |
-1.67 0.95% | 174.84 | 34.61 | 17.04 | 3.46 | 3.39 | 3.16 | 15.49 |
| ISRG Intuitive Surgical Inc |
-1.84 0.45% | 411.06 | 73.05 | 61.73 | 19.15 | 10.25 | 18.41 | 59.92 |
| ESLOF EssilorLuxottica Société anonyme |
- -% | 199.27 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
0.49 0.46% | 106.20 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
-1.11 0.75% | 146.24 | 25.56 | 12.48 | 2.59 | 1.76 | 2.89 | 12.55 |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
410 North Scottsdale Road, Tempe, AZ, United States, 85288
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph M. Hogan | Pres, CEO & Director | 1957 |
| Mr. John F. Morici | CFO & Exec. VP of Global Fin. | 1967 |
| Mr. Emory M. Wright | Exec. VP of Global Operations | 1970 |
| Ms. Julie Ann Coletti | Exec. VP and Chief Legal & Regulatory Officer | 1969 |
| Mr. Stuart Hockridge | Exec. VP of Global HR | 1972 |
| Mr. Zelko Relic | Exec. VP & CTO | 1965 |
| Ms. Shirley Stacy | VP of Corp. Communications & Investor Relations | NA |
| Mr. Vamsi Mohan-Raj Pudipeddi | Exec. VP, Chief Product & Marketing Officer and MD of Asia Pacific | 1972 |
| Mr. Simon Beard | MD for Americas Region & Exec. VP | 1967 |
| Ms. Jennifer Olson-Wilk | Exec. VP of Customer Success | 1978 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...